The same concept worked behind an anti-OX40 aptamer, where Dollins et al. used a DNA scaffold to construct an oligomeric RNA aptamer, which, in turn, acted as an OX40 agonist and stimulated the anti-cancer activity of T cells [66]. The gene discussed is TNFRSF4; the disease is cancer.